Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly S Chien
Dimitrios Farmakiotis
Maria C Rodriguez-Barradas
Daniel M Musher

Showing results (1-10 of 531) with videos related to

Pageof 54
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2012
It's not that simpleKelly S Chien, Dimitrios Farmakiotis, Maria C Rodriguez-Barradas, et al.
Human Vaccines & Immunotherapeutics|May 3, 2014
The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countriesDaniel M Musher, Maria C Rodriguez-Barradas
JAMA Internal Medicine|October 20, 2025
Higher-Valent Pneumococcal Conjugate Vaccines-Perspective for 2026Liset Olarte, Daniel M Musher, Maria C Rodriguez-Barradas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?Daniel M Musher, Rahul Sampath, Maria C Rodriguez-Barradas
The Journal of Infectious Diseases|February 8, 2026
Commensal bacteria: An under-recognized cause of pneumoniaDaniel M Musher, Prathit A Kulkarni, Maria C Rodriguez-Barradas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumoniaDaniel M Musher, Adriana M Rueda-Jaimes, Edward A Graviss, et al.
The Journal of Infectious Diseases|August 20, 2008
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumoniaDaniel M Musher, Adriana M Rueda, Moon H Nahm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccineMaria C Rodriguez-Barradas, Irene Alexandraki, Tabinda Nazir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2013
Photo quiz. To scan or not to scan?Dimitrios Farmakiotis, Kelly Sharon Chien, Thomas Chung Tong Shum, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly personsJose A Serpa, Josemon Valayam, Daniel M Musher, et al.
Pageof 54

Showing results (1-10 of 531) with videos related to

Sort By:
Pageof 54
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 2, 2012
It's not that simpleKelly S Chien, Dimitrios Farmakiotis, Maria C Rodriguez-Barradas, et al.
Human Vaccines & Immunotherapeutics|May 3, 2014
The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countriesDaniel M Musher, Maria C Rodriguez-Barradas
JAMA Internal Medicine|October 20, 2025
Higher-Valent Pneumococcal Conjugate Vaccines-Perspective for 2026Liset Olarte, Daniel M Musher, Maria C Rodriguez-Barradas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?Daniel M Musher, Rahul Sampath, Maria C Rodriguez-Barradas
The Journal of Infectious Diseases|February 8, 2026
Commensal bacteria: An under-recognized cause of pneumoniaDaniel M Musher, Prathit A Kulkarni, Maria C Rodriguez-Barradas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumoniaDaniel M Musher, Adriana M Rueda-Jaimes, Edward A Graviss, et al.
The Journal of Infectious Diseases|August 20, 2008
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumoniaDaniel M Musher, Adriana M Rueda, Moon H Nahm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccineMaria C Rodriguez-Barradas, Irene Alexandraki, Tabinda Nazir, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2013
Photo quiz. To scan or not to scan?Dimitrios Farmakiotis, Kelly Sharon Chien, Thomas Chung Tong Shum, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly personsJose A Serpa, Josemon Valayam, Daniel M Musher, et al.
Pageof 54